Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

Go to Regulatory Recap News

Subscribe for Weekly Updates

The Advocacy &  Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.

Subscribe

Worker Safety

NCCI Issues First in a Series of Workplace Violence Reports

Workplace assaults have increased at a rate of 5.3% per year from 2011-2022, primarily impacting health care and social assistance workers.

Read More →

April 20, 2026

Worker Classification

New York Considers Classifying App-Based Delivery Workers as Employees

If enacted, these workers would be entitled to certain benefits, including workers’ compensation.

Read More →

April 13, 2026

Access to Care

Oregon Extends Treatment Authority to Nurse Practitioners and Physician Associates

Under emergency declaration, the bill went into effect immediately.

Read More →

April 13, 2026

Presumptions

Maryland May Soon Expand Cardiovascular Presumption

Two bills passed both chambers with near unanimous support, but they now sit with the governor under a tight deadline.

Read More →

April 13, 2026

Presumptions

Alabama Enacts Parkinson’s Presumption for Firefighters

The presumption will go into effect October 1st.

Read More →

April 13, 2026

Advocacy Opportunity Treatment Guidelines

California P&T Committee to Address MTUS Updates and Ibuprofen Price Outliers

The April 15th hybrid meeting will take place from 12:30 PM to 2:30 PM PST, covering a wide variety of pharmacy topics.

Read More →

April 13, 2026

Billing & Payments

Louisiana Bill Would Remove Prescription Drugs from MTS Authorization and Appeals

Louisiana introduced a bill that would remove prescribed drugs from the Medical Treatment Schedule (MTS) authorization timelines and Medical Director appeal process under the workers’ compensation law.

Read More →

April 6, 2026

Billing & Payments

West Virginia PBM Bill Bans Spread Pricing

A new West Virginia PBM bill, effective immediately, prohibits spread pricing and requires PBM fees to be transparent and independent of drug cost.

Read More →

April 6, 2026

Mental Health Presumptions

Wisconsin Agreed Bill Expands PTSD Eligibility

On March 31, Wisconsin passed a bill expanding PTSD‑only workers’ compensation claim eligibility for certain first responders and adopting a broader package of agreed‑upon reforms.

Read More →

April 6, 2026

« Previous 1 2 3 4 5 … 52 Next »

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.

hello world!

Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

States Seek to Limit AI-Generated Care Decisions, Despite White House Order

Legislators continue to introduce bills to limit AI-generated healthcare decisions, even as the U.S. Attorney General has been instructed to oppose them.

White House Issues Executive Order to Reschedule Marijuana

Rescheduling marijuana to Schedule III will allow for greater clinical research, possible FDA-approved drugs, and more.

States Consider Expanding Presumptions

So far in 2026, eight states and counting are seeking to expand existing presumptions or create new presumptions.

Could AI-Designed Drugs Impact Regulatory Frameworks?

While AI can be effective in some elements of drug design, AI models currently struggle to explain their decision making, a key component of drug review.